Hematopoietic stem cell transplantation
Disease1 paper
Latest
3International Journal of Molecular SciencesHumans
Donor TET2 variant links to shorter transplant survival
Recipients of stem cells from donors carrying the TET2 Leu1721Trp variant had a median survival of 14.3 months compared with 50.8 months for wild-type…Recipients of stem cells from donors carrying the TET2 Leu1721Trp variant had a median survival of 14.3 months compared with 50.8 months for wild-type donors.